EKF DIAGNOSTICS HOLDINGS PLC — AGM Information 2020

Jun 10, 2020

National Storage Mechanism | Additional information

RNS Number : 5923P

EKF Diagnostics Holdings PLC

10 June 2020

EKF Diagnostics Holdings plc

("EKF" or the "Company")

Results of AGM

EKF Diagnostics Holdings (AIM: EKF), the AIM quoted point-of-care business, announces that at the Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed.

The results of the AGM is available on the Company website: https://www.ekfdiagnostics.com/

Enquiries:

EKF Diagnostics Holdings plc	www.ekfdiagnostics.com
Christopher Mills, Non-Executive Chairman	Tel: 029 2071 0570
Julian Baines, CEO
Richard Evans, FD & COO
N+1 Singer (Nomad & Broker)	Tel: 020 7496 3000
Aubrey Powell / George Tzimas (Corporate Finance) Tom Salvesen (Corporate Broking)
Walbrook PR Limited                                                                           Tel: 020 7933 8780 or ekf@walbrookpr.com
Paul McManus/ Lianne Cawthorne	Mob: 07980 541 893 / 07584 391 303

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)

EKF is a leading point-of-care diagnostics and central laboratory assay manufacturer with an estimated 80,000 hemoglobin, hematocrit, HbA1c, glucose and lactate analyzers in regular use across more than 100 countries. EKF specializes in developing tests for use in anemia and diabetes diagnosis and management, as well as providing a portfolio of reagents for use in clinical chemistry analyzers.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGQBLFFBQLXBBX